Health Canada has issued a recall for some Accu-Chek Guide devices due to inaccurate blood glucose readings. Certain units of the medical measurement device incorrectly display blood glucose levels, ...
Roche Holding RHHBY recently announced that it has received the CE Mark for its Accu-Chek SmartGuide continuous glucose monitoring (CGM) solution. With the approval, CGM solution can now be made ...
The integration of Accu-Chek SmartGuide's AI-enabled predictive CGM with the popular mySugr app delivers a simple, intuitive solution for people to manage their diabetes with greater ease. Accu-Chek ...
Pharmaceuticals maker Roche overhauled its blood glucose monitoring system and introduced a new discounting offer that it says could save uninsured diabetics by thousands of dollars per year. The move ...
Roche RHHBY is set to enter the competitive continuous glucose monitor (CGM) market in Europe following the CE mark approval of its Accu-Chek Smartguide in July. The Swiss pharmaceutical company plans ...
BASEL, Switzerland, Sept. 16, 2025 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) shared real-world evidence from the rollout of Accu-Chek SmartGuide continuous glucose monitoring (CGM) solution ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback